| Filed On | Filing |
|---|---|
| 21 Sep 2026 |
Form 4: Raman Prakash, Director
Received 6,801 shares as a grant or award ($13.1K) |
| 21 Sep 2026 |
Form 4: Behbahani Ali, Director
Received 7,707 shares as a grant or award ($14.9K) |
| 29 Jun 2026 |
Form 4: Kulkarni Samarth, Director
Granted 40,000 Stock Option (Right to Buy) |
| 29 Jun 2026 |
Form 4: Menzel Garry E, Director
Granted 40,000 Stock Option (Right to Buy) |
| 29 Jun 2026 |
Form 4: Raman Prakash, Director
Granted 40,000 Stock Option (Right to Buy) |
| 29 Jun 2026 |
Form 4: Dhingra Kapil, Director
Granted 40,000 Stock Option (Right to Buy) |
| 29 Jun 2026 |
Form 4: Campbell Shannon, Director
Granted 40,000 Stock Option (Right to Buy) |
| 29 Jun 2026 |
Form 4: Behbahani Ali, Director
Granted 40,000 Stock Option (Right to Buy) |
| 22 Jun 2026 |
Form 4: Behbahani Ali, Director
Received 8,961 shares as a grant or award ($14.9K) |
| 22 Jun 2026 |
Form 4: Raman Prakash, Director
Received 7,907 shares as a grant or award ($13.1K) |
| 20 Mar 2026 |
Form 4: Behbahani Ali, Director
Received 6,919 shares as a grant or award ($14.9K) |
| 20 Mar 2026 |
Form 4: Raman Prakash, Director
Received 6,105 shares as a grant or award ($13.1K) |
| 23 Jan 2026 |
Form 4: Jones Erika, SEE REMARKS
Granted 200,000 Stock Option (Right to Buy) |
| 23 Jan 2026 |
Form 4: Buck Elizabeth, CHIEF SCIENTIFIC OFFICER
Granted 250,000 Stock Option (Right to Buy) |
| 23 Jan 2026 |
Form 4: Yurasov Sergey, CHIEF MEDICAL OFFICER
Granted 250,000 Stock Option (Right to Buy) |
| 23 Jan 2026 |
Form 4: Velleca Mark A., Director
Granted 600,000 Stock Option (Right to Buy) |
| 23 Jan 2026 |
Form 4: Hatzis-Schoch Brent, SEE REMARKS
Granted 250,000 Stock Option (Right to Buy) |
| 15 Dec 2025 |
Form 4: Raman Prakash, Director
Received 4,665 shares as a grant or award ($12.9K) |
| 15 Dec 2025 |
Form 4: Behbahani Ali, Director
Received 5,208 shares as a grant or award ($14.4K) |
| 22 Sep 2025 |
Form 4: Behbahani Ali, Director
Received 4,291 shares as a grant or award ($14.4K) |
Loading...